Literature DB >> 9793825

High-dose intravenous gamma-globulins for heparin-induced thrombocytopenia: a prompt response.

A Winder1, Y Shoenfeld, R Hochman, G Keren, Y Levy, A Eldor.   

Abstract

Heparin-induced thrombocytopenia (HIT) is a common drug induced autoimmune condition. The thrombocytopenia is caused in most cases by an antibody directed against the complex PF4/heparin. Recently, we have induced an experimental model of HIT by idiotypic manipulation. To confirm further the idiotypic involvement of HIT, we have treated successfully three patients with HIT with high-dose intravenous gamma-globulin (IVIG). Our three patients joint other two cases previously reported who were treated with IVIG and point to the efficacy of this type of therapy with minimal side effects. IVIG suppression of the anti-PF4/heparin autoantibody may support the idiotypic etiology of HIT.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9793825     DOI: 10.1023/a:1023238915316

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.

Authors:  J Amiral; F Bridey; M Dreyfus; A M Vissoc; E Fressinaud; M Wolf; D Meyer
Journal:  Thromb Haemost       Date:  1992-07-06       Impact factor: 5.249

2.  Heparin-induced thrombocytopenia: effects of rabbit IgG, and its Fab and FC fragments on antibody-heparin-platelet interaction.

Authors:  B H Chong; P A Castaldi; M C Berndt
Journal:  Thromb Res       Date:  1989-07-15       Impact factor: 3.944

3.  Heparin-associated thrombocytopenia: observations on the mechanism of platelet aggregation.

Authors:  B Adelman; M Sobel; Y Fujimura; Z M Ruggeri; T S Zimmerman
Journal:  J Lab Clin Med       Date:  1989-02

Review 4.  Heparin-induced thrombocytopenia.

Authors:  B H Chong
Journal:  Br J Haematol       Date:  1995-03       Impact factor: 6.998

Review 5.  Immunoglobulins and the regulation of autoimmunity through the immune network.

Authors:  S Lacroix-Desmazes; L Mouthon; S H Spalter; S Kaveri; M D Kazatchkine
Journal:  Clin Exp Rheumatol       Date:  1996 May-Jun       Impact factor: 4.473

6.  Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.

Authors:  C Demers; J S Ginsberg; P Brill-Edwards; A Panju; T E Warkentin; D R Anderson; C Turner; J G Kelton
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113

7.  Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides.

Authors:  A Greinacher; I Michels; U Liebenhoff; P Presek; C Mueller-Eckhardt
Journal:  Br J Haematol       Date:  1993-08       Impact factor: 6.998

8.  Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172)

Authors:  H N Magnani
Journal:  Thromb Haemost       Date:  1993-10-18       Impact factor: 5.249

9.  Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.

Authors:  T E Warkentin; C P Hayward; C A Smith; P M Kelly; J G Kelton
Journal:  J Lab Clin Med       Date:  1992-09

10.  Increased expression of platelet IgG Fc receptors in immune heparin-induced thrombocytopenia.

Authors:  B H Chong; R L Pilgrim; M A Cooley; C N Chesterman
Journal:  Blood       Date:  1993-02-15       Impact factor: 22.113

View more
  4 in total

1.  IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.

Authors:  Anand Padmanabhan; Curtis G Jones; Shannon M Pechauer; Brian R Curtis; Daniel W Bougie; Mehraboon S Irani; Barbara J Bryant; Jack B Alperin; Thomas G Deloughery; Kevin P Mulvey; Binod Dhakal; Renren Wen; Demin Wang; Richard H Aster
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

Review 2.  Evidence for the use of intravenous immunoglobulins--a review of the literature.

Authors:  Shaye Kivity; Uriel Katz; Natalie Daniel; Udi Nussinovitch; Neophytos Papageorgiou; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 3.  Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.

Authors:  Gowthami M Arepally; Anand Padmanabhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

4.  Treatment of refractory delayed onset heparin-induced thrombocytopenia after thoracic endovascular aortic repair with intravenous immunoglobulin (IVIG).

Authors:  Kimberley Doucette; Christin B DeStefano; Natasha A Jain; Allan L Cruz; Vera Malkovska; Kelly Fitzpatrick
Journal:  Res Pract Thromb Haemost       Date:  2017-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.